# Kazuhito Shiosakai

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/kazuhito-shiosakai/

## Facts

| Field | Value |
| --- | --- |
| Citations | 876 |
| Field | Blood Pressure and Hypertension Studies |
| h-index | 18 |
| i10-index | 35 |
| Last Known Institution | Daiichi Sankyo (Germany) |
| OpenAlex ID | https://openalex.org/A5004599472 |
| Works | 79 |

## Researcher papers

- [Treatment with trastuzumab deruxtecan in patients with HER2-positive breast cancer and brain metastases and/or leptomeningeal disease (ROSET-BM)](https://scholariq.org/papers/treatment-with-trastuzumab-deruxtecan-in-patients-with-her2-positive-breast/)
- [Efficacy and safety of memantine in patients with moderate-to-severe Alzheimer's disease: results of a pooled analysis of two randomized, double-blind, placebo-controlled trials in Japan](https://scholariq.org/papers/efficacy-and-safety-of-memantine-in-patients-with-moderate-to-severe-alzheimer-s/)
- [Combination of GSH Trapping and Time-Dependent Inhibition Assays as a Predictive Method of Drugs Generating Highly Reactive Metabolites](https://scholariq.org/papers/combination-of-gsh-trapping-and-time-dependent-inhibition-assays-as-a-predictive/)
- [Efficacy and Safety of Add-on Mirogabalin to NSAIDs in Lumbar Spinal Stenosis with Peripheral Neuropathic Pain: A Randomized, Open-Label Study](https://scholariq.org/papers/efficacy-and-safety-of-add-on-mirogabalin-to-nsaids-in-lumbar-spinal-stenosis/)
- [Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)](https://scholariq.org/papers/efficacy-and-safety-of-mirogabalin-for-chemotherapy-induced-peripheral/)
- [Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance](https://scholariq.org/papers/safety-of-the-long-acting-neuraminidase-inhibitor-laninamivir-octanoate-hydrate/)
- [Efficacy and Safety of GPR119 Agonist DS-8500a in Japanese Patients with Type 2 Diabetes: a Randomized, Double-Blind, Placebo-Controlled, 12-Week Study](https://scholariq.org/papers/efficacy-and-safety-of-gpr119-agonist-ds-8500a-in-japanese-patients-with-type-2/)
- [Switching From Pregabalin to Mirogabalin in Patients with Peripheral Neuropathic Pain: A Multi-Center, Prospective, Single-Arm, Open-Label Study (MIROP Study)](https://scholariq.org/papers/switching-from-pregabalin-to-mirogabalin-in-patients-with-peripheral-neuropathic/)
- [Efficacy and Safety of Esaxerenone in Hypertensive Patients with Diabetic Kidney Disease: A Multicenter, Open-Label, Prospective Study](https://scholariq.org/papers/efficacy-and-safety-of-esaxerenone-in-hypertensive-patients-with-diabetic-kidney/)
- [Recommended Iodine Dose for Multiphasic Contrast-Enhanced Mutidetector-Row Computed Tomography Imaging of Liver for Assessing Hypervascular Hepatocellular Carcinoma](https://scholariq.org/papers/recommended-iodine-dose-for-multiphasic-contrast-enhanced-mutidetector-row/)
- [Efficacy and safety of esaxerenone vs trichlormethiazide for the treatment of uncontrolled essential hypertension in Japanese patients with type 2 diabetes mellitus: a subanalysis of the EXCITE-HT study](https://scholariq.org/papers/efficacy-and-safety-of-esaxerenone-vs-trichlormethiazide-for-the-treatment-of/)

## Researcher topics

- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Hormonal Regulation and Hypertension](https://scholariq.org/topics/hormonal-regulation-and-hypertension/)
- [Pain Mechanisms and Treatments](https://scholariq.org/topics/pain-mechanisms-and-treatments/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Researcher university

- [Daiichi Sankyo (Germany)](https://scholariq.org/institutions/daiichi-sankyo-germany/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.